Lexeo Therapeutics, Inc.
LXEO
$5.11
$0.408.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.04% | 342.95% | 284.24% | 152.23% | 57.06% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 62.77% | 72.42% | 12.10% | -- | 20.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.47% | 310.19% | 263.67% | -- | 55.27% |
|
|
|||||
| Total Current Assets | 1.47% | 310.19% | 263.67% | -- | 55.27% |
| Net Property, Plant & Equipment | -13.90% | -11.45% | -10.55% | -- | -10.99% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -- | -0.03% |
| Total Assets | 5.10% | 217.71% | 195.67% | -- | 44.02% |
|
|
|||||
| Total Accounts Payable | 69.14% | 217.82% | 143.35% | -- | 41.67% |
| Total Accrued Expenses | 24.64% | 12.70% | 43.81% | -- | 27.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.50% | 3.27% | -4.40% | -- | -8.08% |
| Total Finance Division Other Current Liabilities | 69.49% | 179.80% | -84.17% | -- | -25.74% |
| Total Other Current Liabilities | 69.49% | 179.80% | -84.17% | -- | -25.74% |
| Total Current Liabilities | 32.53% | 16.42% | 38.19% | -- | 20.14% |
|
|
|||||
| Total Current Liabilities | 32.53% | 16.42% | 38.19% | -- | 20.14% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.69% | -18.42% | -17.06% | -- | -15.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.57% | 6.28% | 15.02% | -- | 5.10% |
|
|
|||||
| Common Stock & APIC | 34.45% | 8,023.59% | 9,826.67% | -- | 11,752.93% |
| Retained Earnings | -54.08% | -51.65% | -52.33% | -- | -57.51% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.91% | 185.58% | 214.85% | 261.97% | 200.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.91% | 185.58% | 214.85% | 261.97% | 200.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.91% | 526.89% | 298.29% | 153.82% | 57.51% |
|
|
|||||